skip to main content
Idioma:
Refinado por: Base de dados/Biblioteca: ScienceDirect remover idioma: Russo remover The Lancet remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial

Baselga, José, Dr ; Bradbury, Ian, PhD ; Eidtmann, Holger, MD ; Di Cosimo, Serena, MD ; de Azambuja, Evandro, MD ; Aura, Claudia, MD ; Gómez, Henry, MD ; Dinh, Phuong, MD ; Fauria, Karine, PhD ; Van Dooren, Veerle, MSc ; Aktan, Gursel, MD ; Goldhirsch, Aron, MD ; Chang, Tsai-Wang, MD ; Horváth, Zsolt, MD ; Coccia-Portugal, Maria, MD ; Domont, Julien, MD ; Tseng, Ling-Min, MD ; Kunz, Georg, MD ; Sohn, Joo Hyuk, MD ; Semiglazov, Vladimir, MD ; Lerzo, Guillermo, MD ; Palacova, Marketa, MD ; Probachai, Volodymyr, MD ; Pusztai, Lajos, DPhil ; Untch, Michael, PhD ; Gelber, Richard D, PhD ; Piccart-Gebhart, Martine, PhD

The Lancet (British edition), 2012-02, Vol.379 (9816), p.633-640 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial
Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial

Bissler, John J, Prof ; Kingswood, J Christopher, FRCP ; Radzikowska, Elżbieta, MD ; Zonnenberg, Bernard A, MD ; Frost, Michael, MD ; Belousova, Elena, Prof ; Sauter, Matthias, MD ; Nonomura, Norio, Prof ; Brakemeier, Susanne, MD ; de Vries, Petrus J, Prof ; Whittemore, Vicky H, PhD ; Chen, David, PhD ; Sahmoud, Tarek, MD ; Shah, Gaurav, MD ; Lincy, Jeremie, MS ; Lebwohl, David, MD ; Budde, Klemens, Prof

The Lancet (British edition), 2013-03, Vol.381 (9869), p.817-824 [Periódico revisado por pares]

Kidlington: Elsevier

Texto completo disponível

Citações Citado por
3
Effect of cruciferous vegetables on lung cancer in patients stratified by genetic status: a mendelian randomisation approach
Effect of cruciferous vegetables on lung cancer in patients stratified by genetic status: a mendelian randomisation approach
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effect of cruciferous vegetables on lung cancer in patients stratified by genetic status: a mendelian randomisation approach

Brennan, Paul ; Hsu, Charles C ; Moullan, Norman ; Szeszenia-Dabrowska, Neonilia ; Lissowska, Jolanta ; Zaridze, David ; Rudnai, Peter ; Fabianova, Eleonora ; Mates, Dana ; Bencko, Vladimir ; Foretova, Lenka ; Janout, Vladimir ; Gemignani, Federica ; Chabrier, Amelie ; Hall, Janet ; Hung, Rayjean J ; Boffetta, Paolo ; Canzian, Federico

The Lancet (British edition), 2005-10, Vol.366 (9496), p.1558-1560 [Periódico revisado por pares]

London: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial
Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial

Bussel, James B, MD ; Provan, Drew, MD ; Shamsi, Tahir, MD ; Cheng, Gregory, MD ; Psaila, Bethan, MD ; Kovaleva, Lidia, MD ; Salama, Abdulgabar, MD ; Jenkins, Julian M, MSc ; Roychowdhury, Debasish, MD ; Mayer, Bhabita, MSc ; Stone, Nicole, PhD ; Arning, Michael, MD

The Lancet (British edition), 2009-02, Vol.373 (9664), p.641-648 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial
The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial

Cleland, John GF, Prof ; Teerlink, John R, Prof ; Senior, Roxy, Prof ; Nifontov, Evgeny M, Prof ; Mc Murray, John JV, Prof ; Lang, Chim C, Prof ; Tsyrlin, Vitaly A, Prof ; Greenberg, Barry H, Prof ; Mayet, Jamil, MD ; Francis, Darrel P, MD ; Shaburishvili, Tamaz, MD ; Monaghan, Mark, PhD ; Saltzberg, Mitchell, MD ; Neyses, Ludwig, Prof ; Wasserman, Scott M, MD ; Lee, Jacqueline H ; Saikali, Khalil G, PhD ; Clarke, Cyril P, MBBS ; Goldman, Jonathan H, MD ; Wolff, Andrew A, MD ; Malik, Fady I, MD

The Lancet (British edition), 2011-08, Vol.378 (9792), p.676-683 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study
Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study

Cortes, Javier, MD ; O'Shaughnessy, Joyce, MD ; Loesch, David, MD ; Blum, Joanne L, MD ; Vahdat, Linda T, MD ; Petrakova, Katarina, MD ; Chollet, Philippe, MD ; Manikas, Alexey, MD ; Diéras, Veronique, MD ; Delozier, Thierry, MD ; Vladimirov, Vladimir, MD ; Cardoso, Fatima, MD ; Koh, Han, MD ; Bougnoux, Philippe, MD ; Dutcus, Corina E, MD ; Seegobin, Seth, MSc ; Mir, Denis, MSc ; Meneses, Nicole, MSHS ; Wanders, Jantien, MD ; Twelves, Chris, Prof

The Lancet (British edition), 2011-03, Vol.377 (9769), p.914-923 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
7
Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study
Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study

Dalton, Tracy, Dr ; Cegielski, Peter, MD ; Akksilp, Somsak, MD ; Asencios, Luis, MPH ; Caoili, Janice Campos, MD ; Cho, Sang-Nae, Prof ; Erokhin, Vladislav V, MD ; Ershova, Julia, PhD ; Gler, Ma Tarcela, MD ; Kazennyy, Boris Y, MD ; Kim, Hee Jin, MD ; Kliiman, Kai, MD ; Kurbatova, Ekaterina, MD ; Kvasnovsky, Charlotte, MD ; Leimane, Vaira, MD ; van der Walt, Martie, PhD ; Via, Laura E, PhD ; Volchenkov, Grigory V, MD ; Yagui, Martin A, MD ; Kang, Hyungseok, MD

The Lancet (British edition), 2012-10, Vol.380 (9851), p.1406-1417 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
8
Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial
Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial

Forette, Françoise ; Seux, Marie-Laure ; Staessen, Jan A ; Thijs, Lutgarde ; Birkenhäger, Willem H ; Babarskiene, Marija-Ruta ; Babeanu, Speranta ; Bossini, Alfredo ; Gil-Extremera, Blas ; Girerd, Xavier ; Laks, Tovio ; Lilov, Emil ; Moisseyev, Valentine ; Tuomilehto, Jaakko ; Vanhanen, Hannu ; Webster, John ; Yodfat, Yair ; Fagard, Robert

The Lancet (British edition), 1998-10, Vol.352 (9137), p.1347-1351 [Periódico revisado por pares]

London: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial

Franz, David Neal, Prof ; Belousova, Elena, MD ; Sparagana, Steven, MD ; Bebin, E Martina, MD ; Frost, Michael, MD ; Kuperman, Rachel, MD ; Witt, Olaf, MD ; Kohrman, Michael H, MD ; Flamini, J Robert, MD ; Wu, Joyce Y, MD ; Curatolo, Paolo, Prof ; de Vries, Petrus J, Prof ; Whittemore, Vicky H, PhD ; Thiele, Elizabeth A, MD ; Ford, James P, MS ; Shah, Gaurav, MD ; Cauwel, Helene, MSc ; Lebwohl, David, MD ; Sahmoud, Tarek, MD ; Jozwiak, Sergiusz, MD

The Lancet (British edition), 2013-01, Vol.381 (9861), p.125-132 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
10
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial

Fuchs, Charles S, Dr Prof ; Tomasek, Jiri, MD ; Yong, Cho Jae, Prof ; Dumitru, Filip, MD ; Passalacqua, Rodolfo, MD ; Goswami, Chanchal, Prof ; Safran, Howard, Prof ; dos Santos, Lucas Vieira, MD ; Aprile, Giuseppe, MD ; Ferry, David R, Prof ; Melichar, Bohuslav, Prof ; Tehfe, Mustapha, MD ; Topuzov, Eldar, Prof ; Zalcberg, John Raymond, Prof ; Chau, Ian, MD ; Campbell, William, Prof ; Sivanandan, Choondal, MD ; Pikiel, Joanna, MD ; Koshiji, Minori, MD ; Hsu, Yanzhi, PhD ; Liepa, Astra M, PharmD ; Gao, Ling, PhD ; Schwartz, Jonathan D, MD ; Tabernero, Josep, MD

The Lancet (British edition), 2014-01, Vol.383 (9911), p.31-39 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de1998  (1)
  2. 1998Até2004  (1)
  3. 2005Até2008  (1)
  4. 2009Até2010  (3)
  5. Após 2010  (11)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.